Welcome to our dedicated page for Community Health Sys SEC filings (Ticker: CYH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Community Health Systems, Inc. filings document the regulatory record of a hospital operator with NYSE-listed common stock and a wholly owned subsidiary that issues senior secured notes, CHS/Community Health Systems, Inc. The company's 8-K reports disclose operating results, Regulation FD information, debt tender offers, senior secured note matters, asset dispositions and related exhibits.
Proxy and governance filings describe board matters, named executive officer compensation, incentive plans and shareholder voting items. Capital-structure disclosures cover common stock registration, senior secured notes due 2031 and 2032, tender-offer mechanics and other material events tied to the company's healthcare delivery assets and outpatient network.
Community Health Systems Inc. director John A. Fry reported multiple equity-related transactions involving restricted stock units (RSUs) and common stock. On March 1 2026, he exercised RSUs that convert to common stock on a one-to-one basis, acquiring 9756, 20906, and 19933 shares of common stock at a stated price of 0.0000 per share. The filing also shows a new grant of 52023 RSUs that vest in one-third increments on the first, second, and third anniversaries of the grant date and will be settled in common stock upon vesting. After these conversions, Fry directly owned 268966 shares of Community Health Systems common stock.
COMMUNITY HEALTH SYSTEMS INC director James S. Ely III reported multiple equity transactions involving restricted stock units and common shares of CYH.
On March 1, 2026, he exercised several blocks of restricted stock units, receiving matching amounts of common stock at a price of $0.00 per share, which increased his direct common stock holdings to 412,876 shares. He also received a new grant of 52,023 restricted stock units that will settle in common stock under the company’s award terms.
Following these transactions, he directly holds 53,779 restricted stock units and 13,085.472 stock units under a directors’ fee deferral plan, each convertible into common stock on a one-for-one basis under specified conditions. In addition, 4,990 common shares are held indirectly through E5 Investors LLC.
COMMUNITY HEALTH SYSTEMS INC director Michael Dinkins reported equity awards and conversions involving restricted stock units and common shares. On 2026-03-01, he exercised or converted restricted stock units into 9,756 and 20,906 shares of common stock at a stated price of $0.0000 per share, increasing his direct common stock holdings to 225,882 shares.
He also acquired a new grant of 52,023 restricted stock units, bringing his directly held restricted stock units to 111,824. The units generally convert to common stock on a one-to-one basis and vest in one-third increments on the first, second, and third anniversaries of the grant date, with some units deferred until he ceases serving as a director or specified future dates.
Community Health Systems director John A. Clerico reported multiple equity transactions dated March 1, 2026. He exercised previously granted restricted stock units that converted one-for-one into 50,595 shares of common stock at a stated price of $0.00 per share.
Clerico also received a new award of 52,023 restricted stock units that vest in equal one-third installments on the first, second and third anniversaries of the grant date and are settled in common shares on a one-for-one basis. Following these transactions, he directly holds 368,763 shares of common stock and 52,023 restricted stock units.
BURGESS RONALD L JR reported acquisition or exercise transactions in this Form 4 filing.
COMMUNITY HEALTH SYSTEMS INC director Ronald L. Burgess Jr. received a grant of 52,023 restricted stock units on March 1, 2026. These units vest in one-third increments on the first, second and third anniversaries of the grant date.
According to his prior deferral elections, the restricted stock units will be settled in an equal number of shares of common stock upon his cessation as a director or on specified future dates. After this grant, he directly held 174,542 restricted stock units and no shares of common stock.
Community Health Systems director Susan W. Brooks reported multiple equity transactions on March 1, 2026. She exercised restricted stock units that convert to common stock on a one-to-one basis, acquiring 50,595 shares of common stock. She also received a new grant of 52,023 restricted stock units, which vest in one-third increments on the first, second and third anniversaries of the grant date and will be settled in common stock on a one-for-one basis. Following these transactions, she directly owned 108,695 shares of common stock and 52,023 restricted stock units.
Community Health Systems, Inc. reports its full-year 2025 results and outlines strategy and industry trends. Net operating revenues were $12,485 million, roughly flat year over year, while net income attributable to stockholders improved to $509 million, reversing prior-year losses.
The company operated 69 hospitals with 10,458 licensed beds and 8,983 beds in service at December 31, 2025, plus more than 1,000 outpatient sites. Same-store net operating revenues rose 4.6%, and income from operations on a same-store basis increased 7.2%, with adjusted EBITDA margin holding at 12.2%.
Operating cash flow strengthened to $543 million, and the company generated $847 million of net cash from investing activities while using $1,167 million in financing activities, reflecting significant debt activity and divestitures. Management highlights initiatives in regional networks, outpatient expansion, productivity, quality programs and adaptation to evolving Medicare, Medicaid and commercial payor dynamics.
Community Health Systems, Inc. reported a sharp turnaround for 2025, moving to net income attributable to stockholders of $509 million or $3.77 per diluted share from a loss of $(516) million or $(3.90) in 2024. Full-year net operating revenues slipped 1.2% to $12.485 billion, but same-store revenue rose 4.6%, showing growth in the ongoing portfolio.
Adjusted EBITDA for 2025 was broadly flat at $1.526 billion, while net cash from operating activities increased to $543 million. Results benefited significantly from $406 million of net non-cash gains on divestitures and asset sales. The company executed a major portfolio reshaping, selling multiple hospitals and its lab outreach business, and received $1.254 billion of hospital and ancillary sale proceeds.
Leverage improved as $445 million of 10.875% senior secured notes due 2032 and all $14 million of 5.625% notes due 2027 were redeemed, helping reduce long-term debt to $10.380 billion. For 2026, management guides to net operating revenues of $11.6–$12.0 billion, Adjusted EBITDA of $1.34–$1.49 billion, and diluted EPS between $(0.60) and $0.00, reflecting expected pressure from divestitures and interest expense.
Community Health Systems Inc. attracted a new significant shareholder disclosure. Investment entities including CastleKnight Master Fund LP, CastleKnight Fund GP LLC, CastleKnight Management LP, CastleKnight Management GP LLC, Weitman Capital LLC, and individual investor Aaron Weitman reported beneficial ownership of 9,748,536 shares of Class A common stock, equal to 7.0% of the outstanding class as of the event date. All reporting persons list zero sole voting or dispositive power and instead share voting and dispositive power over the same 9,748,536 shares. They certify that the position is not held for the purpose of changing or influencing control of Community Health Systems, indicating a passive investment stance.
Community Health Systems, Inc. (CYH) received an amended Schedule 13G/A showing that Eversept Partners, L.P., Eversept 1 LLC and Kamran Moghtaderi jointly report beneficial ownership of 7,943,802 shares of common stock, representing 5.73% of the outstanding class as of the event date.
The reporting persons disclose sole voting and dispositive power over 6,911,186 shares and shared voting and dispositive power over 1,032,616 shares. They state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Community Health Systems.